Rapid Micro Biosystems Inc (NASDAQ:RPID)’s traded shares stood at 0.3 million during the last session, with the company’s beta value hitting 1.08. At the close of trading, the stock’s price was $1.23, to imply an increase of 2.50% or $0.03 in intraday trading. The RPID share’s 52-week high remains $1.45, putting it -17.89% down since that peak but still an impressive 52.85% since price per share fell to its 52-week low of $0.58. The company has a valuation of $52.93M, with an average of 0.18 million shares in intraday trading volume over the past 10 days and average of 100.06K shares over the past 3 months.
Analysts have given a consensus recommendation of Hold for Rapid Micro Biosystems Inc (RPID), translating to a mean rating of 1.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give RPID a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 0 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.22.
Rapid Micro Biosystems Inc (NASDAQ:RPID) trade information
After registering a 2.50% upside in the last session, Rapid Micro Biosystems Inc (RPID) has traded red over the past five days. The 5-day price performance for the stock is 19.42%, and 23.00% over 30 days. With these gigs, the year-to-date price performance is 36.67%. Short interest in Rapid Micro Biosystems Inc (NASDAQ:RPID) saw shorts transact 43583.0 shares and set a 0.77 days time to cover.
The extremes give us $8 and $8 for target low and target high price respectively. As such, RPID has been trading -550.41% off suggested target high and -550.41% from its likely low.
Rapid Micro Biosystems Inc (RPID) estimates and forecasts
Looking at statistics comparing Rapid Micro Biosystems Inc share performance against respective industry, we note that the company has underperformed competitors. Rapid Micro Biosystems Inc (RPID) shares are 86.36% up over the last 6 months, with its year-to-date growth rate lower than industry average at 10.66% against 15.00%. The rating firms project that company’s revenue will grow 21.90% compared to the previous financial year.
Revenue forecast for the current quarter as set by 2 analysts is 7.6M. Meanwhile, for the current quarter, a total of 1 analyst(s) estimate revenue growth to 6.7M.Earnings reports from the last fiscal year show that sales brought in 6.34M and 5.61M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 19.93% before jumping 19.41% in the following quarter.
RPID Dividends
Rapid Micro Biosystems Inc has its next earnings report out in February. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Rapid Micro Biosystems Inc (NASDAQ:RPID)’s Major holders
Rapid Micro Biosystems Inc insiders hold 8.20% of total outstanding shares, with institutional holders owning 57.65% of the shares at 62.80% float percentage. In total, 57.65% institutions holds shares in the company, led by BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC. As of 2024-06-30, the company held over 8.43 million shares (or 19.5038% of shares), all amounting to roughly $5.57 million.
The next major institution holding the largest number of shares is KENNEDY LEWIS MANAGEMENT LP with 4.94 million shares, or about 11.4229% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $3.26 million.
We also have Vanguard Total Stock Market Index Fund and BlackRock Health Sciences Term Trust as the top two Mutual Funds with the largest holdings of the Rapid Micro Biosystems Inc (RPID) shares. Going by data provided on Sep 30, 2024 , Vanguard Total Stock Market Index Fund holds roughly 594.57 shares. This is just over 1.58% of the total shares, with a market valuation of $0.73 million. Data from the same date shows that the other fund manager holds a little less at 571.18, or 1.51% of the shares, all valued at about 0.7 million.
